Policy brief on malaria diagnostics in low-transmission settings
Current evidence indicates that use of microscopy and rapid diagnostic tests (RDTs) is sufficient for clinical management of patients with suspected malaria, routine surveillance and passive case detection in low-transmission areas. While offering a superior diagnostic performance, diagnostic methods based on nucleic acid amplification (NAA) are not required for these applications.
Following the consensus that emerged from the WHO Evidence Review Group meeting held in December 2013 and the March 2014 WHO policy recommendation on malaria diagnostics in low transmission settings, this policy brief provides a list of recommendations on the role, characteristics, performance and applications of these molecular diagnostic tests for malaria in low-transmission areas.
- WHO policy recommendation on malaria diagnostics in low transmission settings (March 2014)
WHO Evidence Review Group on Malaria Diagnosis in Low Transmission Settings - Meeting Report (December 2013)